Figure 6A: Cell viability(%),,,
Control,HG,HG+RSG,HG+RSG+Avastin
99.6%,71.3%,79.2%,77.5%
103.3%,75.3%,89.5%,68.7%
102.4%,83.2%,90.3%,78.3%
93.5%,77.2%,87.7%,63.1%
98.4%,68.7%,85.2%,79.4%
102.8%,64.9%,80.4%,72.6%
,,,
Figure 6B: Tube number,,,
Control,HG,HG+RSG,HG+RSG+Avastin
36,19,33,26
45,22,31,21
35,25,29,18
33,17,27,23
34,21,26,17
37,15,35,27